SHORT BOWEL SYNDROME
Clinical trials for SHORT BOWEL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SHORT BOWEL SYNDROME trials appear
Sign up with your email to follow new studies for SHORT BOWEL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly shot shows promise for bowel disorder patients
Disease control OngoingThis study tests the long-term safety and effectiveness of a weekly injection called glepaglutide in adults with short bowel syndrome, a condition where the body can't absorb nutrients properly. About 129 people who completed a prior trial will receive the drug for 2 years. The g…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug shows promise for managing short bowel syndrome long-term
Disease control OngoingThis study tests the long-term safety of glepaglutide, a medicine for people with short bowel syndrome (SBS). SBS makes it hard for the body to absorb nutrients from food. The trial involves 145 adults who have already taken part in earlier studies. Researchers will track side ef…
Matched conditions: SHORT BOWEL SYNDROME
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New device could help kids with short bowel syndrome eat without IV nutrition
Disease control ENROLLING_BY_INVITATIONThis study looks at a device called RELiZORB that pre-digests fat in tube feedings for children with short bowel syndrome who rely on IV nutrition. The goal is to see if it is safe and helps children absorb nutrients better, possibly reducing their need for IV nutrition. About 32…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug revestive tracked for safety in short bowel patients
Disease control OngoingThis study monitors side effects and how well Revestive (teduglutide) controls symptoms in 250 people with short bowel syndrome. Participants receive injections under the skin as part of their regular care, and doctors watch for any problems over 36 months. The goal is to underst…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Takeda • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New study aims to support families of children with rare diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at the unmet palliative care needs of children with rare diseases and their family caregivers. Researchers will test a program called FACE-Rare to see if it helps families prepare for medical decisions and improves quality of life. About 480 families will take pa…
Matched conditions: SHORT BOWEL SYNDROME
Phase: NA • Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 04:36 UTC
-
Global registry tracks Real-World safety of gut drug
Knowledge-focused OngoingThis study is a global registry that follows people with short bowel syndrome (SBS) over time to see how safe and effective the drug teduglutide is in everyday medical practice. About 1,800 participants, both those taking teduglutide and those not, will be observed. The main goal…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Shire • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC